lhrh, lys(6)- has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K | 1 |
| Arencibia, JM; Groot, K; Halmos, G; Koppán, M; Nagy, A; Plonowski, A; Schally, AV | 1 |
2 other study(ies) available for lhrh, lys(6)- and Adenocarcinoma
| Article | Year |
|---|---|
Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bombesin; Connective Tissue; ErbB Receptors; Gastrin-Releasing Peptide; Gonadotropin-Releasing Hormone; Male; Mitosis; Peptide Fragments; Peptides; Prostatic Neoplasms; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptor, IGF Type 1; Receptors, Bombesin; Testosterone; Time Factors | 1993 |
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Doxorubicin; Drug Delivery Systems; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Nude; Models, Chemical; Polymerase Chain Reaction; Prostatic Neoplasms; Pyrroles; Receptors, LHRH; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |